The integration of the extracellular domain of PD-1 enables CiTEs to block PD-L1 with reduced off-target effects, enhancing T-cell activation, increasing IFN-γ production, and inducing tumor cell lysis [38,39]. Here, IFNG is linked to neoplasm.